Clinical Case Series - 23dlbcl - Question 1

Would you recommend a bispecific antibody to your patient with relapsed DLBCL who has a history of CRS and ICANS and for whom CAR T-cell therapy previously failed?

Yes
No
It depends on the patient and the severity of the toxicity
I would consider an alternate therapy approved for relapsed/refractory DLBCL
{"name":"Clinical Case Series - 23dlbcl - Question 1", "url":"https://www.poll-maker.com/QB1YKR5BY","txt":"Would you recommend a bispecific antibody to your patient with relapsed DLBCL who has a history of CRS and ICANS and for whom CAR T-cell therapy previously failed?","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}
Tools: Poll Maker | Quiz Maker | Super Surveys